BLOOD SAVING TO PATIENTS WITH HIP FRACTURE WHO ARE TREATED WITH HEMIARTHROPLASTY – PRELIMINARY RESULTS.

E Fotinopoulos; D Pafilas; D Kanellopoulos; Th Tsirlis; N. Kourtzis

doi:10.1302/0301-620X.86BSUPP_II.0860179b

Current issue

BLOOD SAVING TO PATIENTS WITH HIP FRACTURE WHO ARE TREATED WITH HEMIARTHROPLASTY – PRELIMINARY RESULTS.

E Fotinopoulos
D Pafilas
D Kanellopoulos
Th Tsirlis
N. Kourtzis

BLOOD SAVING TO PATIENTS WITH HIP FRACTURE WHO ARE TREATED WITH HEMIARTHROPLASTY – PRELIMINARY RESULTS.

Fotinopoulos E, Pafilas D, Kanellopoulos D, Tsirlis T, Kourtzis N. BLOOD SAVING TO PATIENTS WITH HIP FRACTURE WHO ARE TREATED WITH HEMIARTHROPLASTY – PRELIMINARY RESULTS.. Orthop Procs. 2004;86-B(SUPP_II):179-179. doi:10.1302/0301-620X.86BSUPP_II.0860179b

Fotinopoulos, E, et al. “BLOOD SAVING TO PATIENTS WITH HIP FRACTURE WHO ARE TREATED WITH HEMIARTHROPLASTY – PRELIMINARY RESULTS..” Orthopaedic Proceedings, vol. 86-B, no. SUPP_II, 2004, pp. 179-179., https://doi.org/10.1302/0301-620X.86BSUPP_II.0860179b

Fotinopoulos, E., Pafilas, D., Kanellopoulos, D., Tsirlis, T., & Kourtzis, N. (2004). BLOOD SAVING TO PATIENTS WITH HIP FRACTURE WHO ARE TREATED WITH HEMIARTHROPLASTY – PRELIMINARY RESULTS.. Orthopaedic Proceedings, 86-B(SUPP_II), 179-179. https://doi.org/10.1302/0301-620X.86BSUPP_II.0860179b

Fotinopoulos, E., Pafilas, D., Kanellopoulos, D., Tsirlis, T. and Kourtzis, N. (2004) “BLOOD SAVING TO PATIENTS WITH HIP FRACTURE WHO ARE TREATED WITH HEMIARTHROPLASTY – PRELIMINARY RESULTS..” Orthopaedic Proceedings, 86-B(SUPP_II), pp. 179-179. Available at: https://doi.org/10.1302/0301-620X.86BSUPP_II.0860179b

Fotinopoulos, E, D Pafilas, D Kanellopoulos, Th Tsirlis, and N. Kourtzis. “BLOOD SAVING TO PATIENTS WITH HIP FRACTURE WHO ARE TREATED WITH HEMIARTHROPLASTY – PRELIMINARY RESULTS..” Orthopaedic Proceedings 86-B, no. SUPP_II (2004): 179-179. https://doi.org/10.1302/0301-620X.86BSUPP_II.0860179b

Fotinopoulos E, Pafilas D, Kanellopoulos D, Tsirlis T, Kourtzis N. BLOOD SAVING TO PATIENTS WITH HIP FRACTURE WHO ARE TREATED WITH HEMIARTHROPLASTY – PRELIMINARY RESULTS.. Orthop Procs. 2004 Feb 1;86-B(SUPP_II):179-179. https://doi.org/10.1302/0301-620X.86BSUPP_II.0860179b

Copy to clipboard

Mendeley

BibTeX

EndNote

RIS

Abstract

This randomized study is about 100 patients with hip fracture that were treated with hemiarthroplasty in 4 groups of 25.

Group A includes patients who were given :

- recombined human erythropoetin (r-HuEPO) 40.000 I.U. sc the day −1, +1, +3, +7 (day 0 = day of surgery).
- sulfate iron per os from the day −1 till +15
- blood from the autotranfusion apparatus (it is the patient’s blood that is collected in the autotransfusion apparatus the 5 first postoperative hours).

Group B includes patients who were given :

- sulfate iron per os from the day −1 till +15
- blood from the autotranfusion apparatus

Group C includes patients who were given :

- recombined human erythropoetin (r-HuEPO) 40.000 I.U. sc the day −1, +1, +3, +7 (day 0 = day of surgery).
- sulfate iron per os from the day −1 till +15

Group D is the control group (that was not given none of the above therapies).

We study and present the first results of the effect of the recombined erythropoetin, the sulfate iron per os and the patient’s blood from the autotransfusion apparatus to patients with hip fracture who were treated with hemiarthroplasty in concern to the transfused blood units for the restoration of the hematocrit to a tolerable level.

The abstracts were prepared by Eleni Koutsoukou. Correspondence should be addressed to him at the Hellenic Association of Orthopaedic Surgery and Traumatology (HAOST), 20, A. Fleming str, 15123 Marousi, Athens, Greece.